Goldman Sachs cuts Dynavax stock rating to sell, target to $12
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...
As DEI goes under the knife, CEOs are still on the hook for inclusion strategies linked to compensation
Companies pledged to pay execs for hitting DEI-related goals, but now that “DEI” is on the outs, companies are giving their plans a facelift.
Goldman Sachs’ Exclusive Investing Club Is a Powerful Draw
Employees’ privileged access to its own funds show a widening compensation gap on Wall Street. Marc Rubinstein is a former ...
Swiss testing company SGS reports higher full year sales and profit
Swiss testing and certification company SGS on Tuesday reported full year sales in line with forecasts and slightly better ...
DGRO: A Defensive ETF For A Shifting Market Environment
DGRO's strategy focuses on diverse sector allocations, emphasizing technology, financials, and healthcare. Read what makes ...
Goldman Sachs Bangs the Drum on Alphabet Stock
Alphabet (NASDAQ:GOOGL) stock took a hit last week after its Q4 earnings report received a thumbs down from Wall Street. The market’s ...
Hedge Funds Are Pocketing Much of Their Clients’ Gains With ‘No Limit’ Fees
A Bloomberg analysis of the major hedge funds’ regulatory filings shows their passthrough fees have exploded in recent years.
Opera Limited (NASDAQ:OPRA) Receives $24.75 Consensus PT from Brokerages
Shares of Opera Limited (NASDAQ:OPRA – Get Free Report) have received an average rating of “Buy” from the five analysts that are covering the firm, Marketbeat Ratings reports. Five investment analysts ...
The ‘Magnificent Seven’ companies just did something they haven’t in two years. Goldman says it’s time to make a shift.
It’s a sea of green this morning — congrats Eagles fans — with Wall Street also pointing to a higher start, led by tech. If ...